Standex International Corporation Aktie News

Standex International Corporation (SXI) Q2 2026 Earnings Call Transcript

In Q2 FY26, Sales Increased 16.6% YOY to $221.3 Million; New Products Sales Grew ~13% and Sales into Fast Growth Markets Contributed ~28% of Total Sales In Q2 FY26, Sales Increased 6.4% YOY Organically; Electronics Increased 11.1% YOY Organically Record Quarterly Order Intake with Book to Bill of 1.04; Electronics Book to Bill of 1.08 Q2 FY26 GAAP Operating Margin of 16.1%; Adjusted Operating M...

SALEM, N.H., Jan. 23, 2026 /PRNewswire/ --  Standex International Corporation (NYSE: SXI) today announced that its Board of Directors has declared a quarterly cash dividend of $0.34 per share, an approximately 6.3% year-on-year increase.

SALEM, N.H., Jan. 23, 2026 /PRNewswire/ --  Standex International Corporation (NYSE: SXI) will announce its second quarter fiscal 2026 financial results on Thursday, January 29, 2026 after the close of the market and will broadcast its conference call live over the Internet at 8:30 a.m.

SALEM, N.H., Jan. 6, 2026 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) announced today that David Dunbar, President & CEO, and Ademir Sarcevic, CFO, will be presenting at the CJS Securities 26th Annual New Ideas for the New Year Virtual Conference on Wednesday, January 14, 2026.

North Carolina-based Anchor Capital Management Company added 29,998 shares of SXI in the third quarter. The move contributed to a net position change of $10.15 million from the previous period.

SALEM, N.H. , Nov. 21, 2025 /PRNewswire/ -- Standex International Corporation (NYSE:SXI) announced today that David Dunbar, President & CEO, will be participating in the Melius Research Conference in New York City on Wednesday, December 10, 2025.

Standex International Corporation ( SXI ) Q1 2026 Earnings Call October 31, 2025 8:30 AM EDT Company Participants Huang Howe - Director of Investor Relations David Dunbar - Chairman, President & CEO Ademir Sarcevic - VP, CFO & Treasurer Conference Call Participants Christopher Moore - CJS Securities, Inc. Ross Sparenblek - William Blair & Company L.L.C., Research Division Michael Shlisky - D.A.